Blog
RSS FeedPosted by Michael Wonder on 16 Feb 2023
Living health technology assessments: how close to living reality?
16 February 2023 - HTA processes have remained largely unchanged, but innovative study designs (eg, pragmatic and adaptive clinical trials, single-arm ...
Posted by Michael Wonder on 19 Jan 2022
UK’s NICE to launch sweeping changes to drug assessments to be faster, more agile
19 January 2022 - The health technology assessment body has been under pressure from drugmakers and patient groups for years to ...
Posted by Michael Wonder on 19 Apr 2021
NICE launches ambitious strategy to provide quicker access to new treatments and innovations
19 April 2021 - NICE will transform key elements of its approach to ensure efficiency and speed while maintaining robust, trusted ...
Posted by Michael Wonder on 30 Mar 2021
NICE methods and process review aims to create fertile ground for innovation
29 March 2021 - The way NICE reviews new medicines is about to go through its biggest change in years – ...
Posted by Michael Wonder on 26 Jun 2019
NICE to make changes to health technology evaluation
26 June 2019 - The Voluntary Scheme for Branded Medicines Pricing and Access, agreed by government and the ABPI in ...
Posted by Michael Wonder on 26 Aug 2018
Evidence required by heath technology assessment and reimbursement bodies evaluating diagnostic or prognostic algorithms that include omics data
23 August 2018 - Multi-analyte assays with algorithmic analyses use combinations of circulating and clinical markers including omics-based sources for diagnostic ...